Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 1, 2013, Pages 34-41

  Waeckerle Men, Ying ^a   Mauracher, Andrea ^a   Håkerud, Monika ^b   Mohanan, Deepa ^a   Kündig, Thomas M ^a   Høgset, Anders ^b   Johansen, Pål ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b PCI Biotech AS   (Norway)

Author keywords

Adjuvants; Amphinex; Antigen presentation; Apoptosis; Immunisation; Mice; Photosensitiser; T cells; Vaccines

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DISRUPTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; DENDRITIC CELL; ENDOCYTOSIS; ENDOSOME; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTOCHEMICAL INTERNALIZATION; T LYMPHOCYTE; VACCINATION;

ADJUVANTS; AMPHINEX; ANTIGEN PRESENTATION; APOPTOSIS; IMMUNISATION; MICE; PHOTOSENSITISER; T CELLS; VACCINES;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; BONE MARROW CELLS; CELLS, CULTURED; CYTOSOL; DENDRITIC CELLS; ENDOCYTOSIS; ENDOSOMES; FEASIBILITY STUDIES; FEMALE; GENES, MHC CLASS I; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON-GAMMA RELEASE TESTS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOTOSENSITIZING AGENTS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES;

EID: 84882984165     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.02.002     Document Type: Article

References (74)

1. L. Rajendran, H.J. Knolker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
2. J.W. Yoo, D.J. Irvine, D.E. Discher, and S. Mitragotri Bio-inspired, bioengineered and biomimetic drug delivery carriers Nat. Rev. Drug Discov. 10 2011 521 535
3. P.K. Selbo, M.G. Rosenblum, L.H. Cheung, W. Zhang, and K. Berg Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel PLoS One 4 2009 e6691
4. K. Berg, M. Folini, L. Prasmickaite, P.K. Selbo, A. Bonsted, B.O. Engesaeter, N. Zaffaroni, A. Weyergang, A. Dietze, G.M. Maelandsmo, E. Wagner, O.J. Norum, and A. Hogset Photochemical internalization: a new tool for drug delivery Curr. Pharm. Biotechnol. 8 2007 362 372
5. D.E. Dolmans, D. Fukumura, and R.K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 3 2003 380 387
6. P.L. Lollini, F. Cavallo, P. Nanni, and G. Forni Vaccines for tumour prevention Nat. Rev. Cancer 6 2006 204 216
7. M.A. Morse, S. Chui, A. Hobeika, H.K. Lyerly, and T. Clay Recent developments in therapeutic cancer vaccines Nat. Clin. Pract. Oncol. 2 2005 108 113
8. M. Vanneman, and G. Dranoff Combining immunotherapy and targeted therapies in cancer treatment Nat. Rev. Cancer 12 2012 237 251
9. K. Palucka, and J. Banchereau Cancer immunotherapy via dendritic cells Nat. Rev. Cancer 12 2012 265 277
10. V. Appay, D.C. Douek, and D.A. Price CD8+ T cell efficacy in vaccination and disease Nat. Med. 14 2008 623 628
11. University-College-London, Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients with Cutaneous Cancer, in: ClinicalTrials.gov, National Library of Medicine (US), Bethesda (MD), 2009, pp. NLM Identifier: NCT00004451.
12. B.J. Druker, S. Tamura, E. Buchdunger, S. Ohno, G.M. Segal, S. Fanning, J. Zimmermann, and N.B. Lydon Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat. Med. 2 1996 561 566
13. R.S. Finn, and A.X. Zhu Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab Expert Rev. Anticancer Ther. 9 2009 503 509
14. D.F. Hayes, A.D. Thor, L.G. Dressler, D. Weaver, S. Edgerton, D. Cowan, G. Broadwater, L.J. Goldstein, S. Martino, J.N. Ingle, I.C. Henderson, L. Norton, E.P. Winer, C.A. Hudis, M.J. Ellis, and D.A. Berry HER2 and response to paclitaxel in node-positive breast cancer N. Engl. J. Med. 357 2007 1496 1506
15. V.L. Heath, and R. Bicknell Anticancer strategies involving the vasculature Nat. Rev. Clin. Oncol. 6 2009 395 404
16. C.A. Hudis Trastuzumab-mechanism of action and use in clinical practice N. Engl. J. Med. 357 2007 39 51
17. D. Pytel, T. Sliwinski, T. Poplawski, D. Ferriola, and I. Majsterek Tyrosine kinase blockers: new hope for successful cancer therapy Anticancer Agents Med. Chem. 9 2009 66 76
18. R.D. Carpenter, M. Andrei, O.H. Aina, E.Y. Lau, F.C. Lightstone, R. Liu, K.S. Lam, and M.J. Kurth Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin J. Med. Chem. 52 2009 14 19
19. E. Garanger, D. Boturyn, and P. Dumy Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers Anticancer Agents Med. Chem. 7 2007 552 558
20. Y. Gupta, D.V. Kohli, and S.K. Jain Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents Crit. Rev. Ther. Drug Carrier Syst. 25 2008 347 379
21. J.M. Irache, H.H. Salman, C. Gamazo, and S. Espuelas Mannose-targeted systems for the delivery of therapeutics Expert Opin. Drug Deliv. 5 2008 703 724
22. J.M. Lambert Drug-conjugated monoclonal antibodies for the treatment of cancer Curr. Opin. Pharmacol. 5 2005 543 549
23. P.S. Low, and S.A. Kularatne Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13 2009 256 262
24. H. Modjtahedi, and S. Essapen Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities Anticancer Drugs 20 2009 851 855
25. A.V. Rao, and K. Schmader Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults Am. J. Geriatr. Pharmacother. 5 2007 247 262
26. S.D. Conner, and S.L. Schmid Regulated portals of entry into the cell Nature 422 2003 37 44
27. S. Saffarian, E. Cocucci, and T. Kirchhausen Distinct dynamics of endocytic clathrin-coated pits and coated plaques PLoS Biol. 7 2009 e1000191
28. A. Sorkin, and M. von Zastrow Endocytosis and signalling: intertwining molecular networks Nat. Rev. Mol. Cell Biol. 10 2009 609 622
29. K. Berg, P.K. Selbo, L. Prasmickaite, T.E. Tjelle, K. Sandvig, J. Moan, G. Gaudernack, O. Fodstad, S. Kjolsrud, H. Anholt, G.H. Rodal, S.K. Rodal, and A. Hogset Photochemical internalization: a novel technology for delivery of macromolecules into cytosol Cancer Res. 59 1999 1180 1183
30. K. Berg, A. Weyergang, L. Prasmickaite, A. Bonsted, A. Hogset, M.T. Strand, E. Wagner, and P.K. Selbo Photochemical internalization (PCI): a technology for drug delivery Methods Mol. Biol. 635 2010 133 145
31. L. Prasmickaite, A. Hogset, and K. Berg Evaluation of different photosensitizers for use in photochemical gene transfection Photochem. Photobiol. 73 2001 388 395
32. B. Guy The perfect mix: recent progress in adjuvant research Nat. Rev. Microbiol. 5 2007 505 517
33. C.W. Cluff Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results Adv. Exp. Med. Biol. 667 2009 111 123
34. C. Olive Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants Expert Rev. Vaccines 11 2012 237 256
35. C.A. Janeway Jr. Approaching the asymptote? Evolution and revolution in immunology Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1 1989 1 13
36. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka Immunobiology of dendritic cells Annu. Rev. Immunol. 18 2000 767 811
37. C. Segundo, F. Medina, C. Rodriguez, R. Martinez-Palencia, F. Leyva-Cobian, and J.A. Brieva Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis Blood 94 1999 1012 1020
38. O.K. Nihei, A.C. de Carvalho, W. Savino, and L.A. Alves Pharmacologic properties of P(2Z)/P2X(7) receptor characterized in murine dendritic cells: role on the induction of apoptosis Blood 96 2000 996 1005
39. R. Harrop, J. John, and M.W. Carroll Recombinant viral vectors: cancer vaccines Adv. Drug Deliv. Rev. 58 2006 931 947
40. S.J. Draper, and J.L. Heeney Viruses as vaccine vectors for infectious diseases and cancer Nat. Rev. Microbiol. 8 2010 62 73
41. A. Bolhassani, S. Safaiyan, and S. Rafati Improvement of different vaccine delivery systems for cancer therapy Mol. Cancer 10 2011 3
42. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 2007 748 758
43. S. Palakurthi, V.K. Yellepeddi, A. Kumar, Nanocarriers for cytosolic drug and gene delivery in cancer therapy, in: S. Olsztynska (Ed.), Biomedical Engineering: Trends, Research and Technologies, 2011, pp. 245-272.
44. H. Akita, K. Kogure, R. Moriguchi, Y. Nakamura, T. Higashi, T. Nakamura, S. Serada, M. Fujimoto, T. Naka, S. Futaki, and H. Harashima Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation J. Control. Release 143 2010 311 317
45. S.S. Bale, S.J. Kwon, D.A. Shah, A. Banerjee, J.S. Dordick, and R.S. Kane Nanoparticle-mediated cytoplasmic delivery of proteins to target cellular machinery ACS Nano 4 2010 1493 1500
46. M. Breunig, S. Bauer, and A. Goepferich Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68 2008 112 128
47. J.P. Behr Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy Bioconjug. Chem. 5 1994 382 389
48. T. Bieber, W. Meissner, S. Kostin, A. Niemann, and H.P. Elsasser Intracellular route and transcriptional competence of polyethylenimine-DNA complexes J. Control. Release 82 2002 441 454
49. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728
50. S. Foster, C.L. Duvall, E.F. Crownover, A.S. Hoffman, and P.S. Stayton Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy Bioconjug. Chem. 21 2010 2205 2212
51. B. Gupta, T.S. Levchenko, and V.P. Torchilin Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides Adv. Drug Deliv. Rev. 57 2005 637 651
52. Y. Waeckerle-Men, E. Uetz-von Allmen, M. Fopp, R. von Moos, C. Bohme, H.P. Schmid, D. Ackermann, T. Cerny, B. Ludewig, M. Groettrup, and S. Gillessen Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma Cancer Immunol. Immunother. 55 2006 1524 1533
53. L. Galluzzi, L. Senovilla, E. Vacchelli, A. Eggermont, W.H. Fridman, J. Galon, C. Sautes-Fridman, E. Tartour, L. Zitvogel, and G. Kroemer Trial watch: dendritic cell-based interventions for cancer therapy Oncoimmunology 1 2012 1111 1134
54. P. Machy, K. Serre, and L. Leserman Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells Eur. J. Immunol. 30 2000 848 857
55. T. Yoshikawa, N. Okada, M. Tsujino, J.Q. Gao, A. Hayashi, Y. Tsutsumi, T. Mayumi, A. Yamamoto, and S. Nakagawa Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma Biol. Pharm. Bull. 29 2006 100 104
56. P. Elamanchili, C.M. Lutsiak, S. Hamdy, M. Diwan, and J. Samuel "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells J. Immunother. 30 2007 378 395
57. S. Hamdy, A. Haddadi, R.W. Hung, and A. Lavasanifar Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations Adv. Drug Deliv. Rev. 63 2011 943 955
58. H. Li, Y. Li, J. Jiao, and H.M. Hu Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response Nat. Nanotechnol. 6 2011 645 650
59. Y. Mukai, T. Yoshinaga, M. Yoshikawa, K. Matsuo, T. Yoshikawa, K. Niki, Y. Yoshioka, N. Okada, and S. Nakagawa Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (gamma-glutamic acid) nanoparticles J. Immunol. 187 2011 6249 6255
60. E.A. Scott, A. Stano, M. Gillard, A.C. Maio-Liu, M.A. Swartz, and J.A. Hubbell Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes Biomaterials 33 2012 6211 6219
61. A.M. Hafner, D. Burschowsky, B. Corthesy, M. Textor, and H.P. Merkle Surface assembly of poly(I:C) on PEGylated microspheres to shield from adverse interactions with fibroblasts J. Control. Release 159 2012 204 214
62. A.M. Hafner, B. Corthesy, M. Textor, and H.P. Merkle Tuning the immune response of dendritic cells to surface-assembled poly(I:C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling Biomaterials 32 2011 2651 2661
63. U. Wattendorf, and H.P. Merkle PEGylation as a tool for the biomedical engineering of surface modified microparticles J. Pharm. Sci. 97 2008 4655 4669
64. U. Wattendorf, G. Coullerez, J. Voros, M. Textor, and H.P. Merkle Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells Langmuir 24 2008 11790 11802
65. J.M. Martinez Gomez, S. Fischer, N. Csaba, T.M. Kundig, H.P. Merkle, B. Gander, and P. Johansen A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles Pharm. Res. 24 2007 1927 1935
66. U. Wattendorf, M.C. Koch, E. Walter, J. Voros, M. Textor, and H.P. Merkle Phagocytosis of poly(l-lysine)-graft-poly(ethylene glycol) coated microspheres by antigen presenting cells: Impact of grafting ratio and poly(ethylene glycol) chain length on cellular recognition Biointerphases 1 2006 123 133
67. Y. Waeckerle-Men, E.U. Allmen, B. Gander, E. Scandella, E. Schlosser, G. Schmidtke, H.P. Merkle, and M. Groettrup Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells Vaccine 24 2006 1847 1857
68. S. Jilek, H.P. Merkle, and E. Walter DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells Adv. Drug Deliv. Rev. 57 2005 377 390
69. L. Thiele, H.P. Merkle, and E. Walter Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages Pharm. Res. 20 2003 221 228
70. J.M. Weiss, C. Allen, R. Shivakumar, S. Feller, L.H. Li, and L.N. Liu Efficient responses in a murine renal tumor model by electroloading dendritic cells with whole-tumor lysate J. Immunother. 28 2005 542 550
71. K.W. Kim, S.H. Kim, J.H. Jang, E.Y. Lee, S.W. Park, J.H. Um, Y.J. Lee, C.H. Lee, S. Yoon, S.Y. Seo, M.H. Jeong, S.T. Lee, B.S. Chung, and C.D. Kang Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity Cancer Immunol. Immunother. 53 2004 315 322
72. I. Danylesko, K. Beider, A. Shimoni, and A. Nagler Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions Clin. Dev. Immunol. 2012 2012 753407
73. R. Yamanaka, and K. Kajiwara Dendritic cell vaccines Adv. Exp. Med. Biol. 746 2012 187 200
74. R. Klippstein, and D. Pozo Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies Nanomedicine 6 2010 523 529